Aarti Pharmalabs Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
AARTIPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aarti Pharmalabs has informed the exchanges that its insider trading window will remain closed from July 1, 2025 until 48 hours after the company declares its financial results for the quarter ending June 30, 2025 (Q1 FY26). During this period, designated persons, connected persons, and their relatives are prohibited from trading in the company's shares. The exact date of the board meeting to approve these quarterly results has not yet been disclosed and will be communicated later. This is a standard compliance filing under SEBI's Prohibition of Insider Trading Regulations, 2015.
This is a routine regulatory disclosure with no direct impact on shareholders. However, it signals that the Q1 FY26 earnings announcement is approaching, which may bring near-term stock volatility depending on the reported numbers.